Skip to main content
Clinical Trials/NL-OMON20641
NL-OMON20641
Completed
Not Applicable

A randomised, double-blind, controlled study to assess the effect of an Amino Acid based Formula with a synbiotic blend on gut microbiota diversity and clinical effectiveness in infants with suspected gastrointestinal non-IgE mediated Cow’s Milk Allergy.

Danone Research – Centre for Specialised Nutrition0 sites68 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cow's milk allergy
Sponsor
Danone Research – Centre for Specialised Nutrition
Enrollment
68
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Danone Research – Centre for Specialised Nutrition

Eligibility Criteria

Inclusion Criteria

  • 1\. Infants \<13 months of age i.e. up to and including the day before the infant is 13 months of age;
  • 2\. Clinical history or strong suspicion of an allergic reaction to cow’s milk protein AND WITH at least one of the following (gastrointestinal) symptoms present at study entry:
  • A. Chronic pPoor weight gain AFTER the dietary inclusion of cow’s milk protein;
  • B. Frequent (daily) regurgitation or vomiting whereby symptoms are RELATED to the cow’s milk protein and not merely functional vomiting;
  • C. Extended periods of diarrhoea with a negative stool examination (laboratory tests negative);
  • D. Soft stool constipation (with/without perianal rash NOT due to infection);
  • E. Blood in stool;
  • F. Iron deficiency anaemia due to occult or macroscopic blood loss in stools NOT due to infection or dietary insufficiency;
  • G. Endoscopically confirmed eosinophilic enteropathy;
  • H. Persistent distress or colic (\> 3 hours per day at least 3 days a week over 3 week period).

Exclusion Criteria

  • 1\. Infants less than 2500 g at birth;
  • 2\. Infants less than 37 weeks gestation who require specific premature formula at the time of study entry;
  • 3\. Infants with severe concurrent illness;
  • 4\. Infants with functional gastrointestinal symptoms where atopy and food allergy is NOT suspected;
  • 5\. Infants with immune autoimmune or gluten sensitive enteropathy;
  • 6\. Infants with Food Protein\-Induced Enterocolitis Syndrome (FPIES);
  • 7\. Infants who have acute or chronic diarrhea secondary to confirmed infectious gastroenteritis (laboratory tests positive);
  • 8\. Behavioural disorders with food aversion or food phobia;
  • 9\. Infants who have undergone gastrointestinal surgery such as bowel resection or stoma placement;
  • 10\. Infants with Down syndrome or other syndromes where functional gastrointestinal disorders are common;

Outcomes

Primary Outcomes

Not specified

Similar Trials